Real-world efficacy and safety of donafenib-based therapies in patients with unresectable hepatocellular carcinoma: A retrospective study.

被引：0
|
作者：
Shang, Changzhen [1 ]
Luo, Xuan [1 ]
Zhong, Jinyi [1 ]
Zhang, Jianlong [1 ]
Li, Huilong [1 ]
Tan, Wenliang [1 ]
Lei, Zhang [1 ]
Chen, Yajin [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16169
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: A multicenter, retrospective real-world study in China
    Zhang, Hui
    Shao, Minghua
    Tan, Binbin
    Fu, Yin
    Yuan
    Chen, Hailei
    CANCER RESEARCH, 2024, 84 (06)
  • [22] Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study
    Haohao Lu
    Bin Liang
    Xiangwen Xia
    Chuansheng Zheng
    BMC Cancer, 23
  • [23] The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study
    Wang, Xishu
    Sun, Ximin
    Lei, Yongrong
    Fang, Lingyan
    Wang, Yuedi
    Feng, Kai
    Xia, Feng
    BMC CANCER, 2024, 24 (01)
  • [24] THE EFFICACY AND SAFETY OF ATEZOLIZUMAB & BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: THE REAL WORLD DATA
    Yoo, Sung Hwan
    Lee, Hyun Woong
    Lee, Jung Il
    HEPATOLOGY, 2023, 78 : S1898 - S1899
  • [25] Efficacy and safety of apatinib in treatment of unresectablehepatocellular carcinoma: A real-world study.
    Liu, Jun
    Li, Guangbing
    He, Qiang
    Sun, Shijun
    Zhao, Chuanlin
    Sun, Chuandong
    Zhang, Bo
    Cui, Yi
    Ye, Yongqiang
    Zhi, Xuting
    Li, Shiping
    Li, Shiping
    Pan, Guozheng
    Ma, Changlin
    Hu, Jinhua
    Li, Jun
    Wang, Suling
    Qiao, Yuangang
    Ren, Wanhua
    Meng, Qi
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
    Bang, Yeong Hak
    Lee, Choong-kun
    Yoo, Changhoon
    Chon, Hong Jae
    Hong, Moonki
    Kang, Beodeul
    Kim, Hyung-Don
    Park, Sook Ryun
    Choi, Won-Mook
    Choi, Jonggi
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [27] Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
    Cheon, Jaekyung
    Chon, Hong Jae
    Bang, Yeonghak
    Park, Neung Hwa
    Shin, Jung Woo
    Kim, Kang Mo
    Lee, Han Chu
    Lee, Jooho
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    LIVER CANCER, 2020, 9 (05) : 613 - 624
  • [28] Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysis
    Cheon, J.
    Yoo, C.
    Bang, Y.
    Chon, H.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1308 - S1308
  • [29] Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study
    Feng, Jin-Kai
    Sun, Ju-Xian
    Liu, Zong-Han
    Gu, Jing-Wen
    Chen, Zhen-Hua
    Liu, Chang
    Guo, Wei-Xing
    Shi, Jie
    Cheng, Shu-Qun
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3551 - 3560
  • [30] Clinical efficacy and safety in gastric cancer patients treated with apatinib: A retrospective real-world study.
    Li, Ning
    Du, Yali
    Deng, Wenying
    Ma, Yijie
    Yang, Xinyi
    Bie, Liangyu
    Wu, Qiong
    Yang, Haiying
    Luo, Suxia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345